REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,573,740 | +1.0% | 79,905 | -15.4% | 0.51% | -8.7% |
| Q3 2022 | $2,549,000 | +138.4% | 94,413 | +122.0% | 0.55% | +119.0% |
| Q3 2020 | $1,069,000 | +38.8% | 42,537 | +34.8% | 0.25% | +48.8% |
| Q2 2020 | $770,000 | -39.0% | 31,552 | -63.0% | 0.17% | -56.6% |
| Q1 2020 | $1,262,000 | -26.2% | 85,302 | -19.1% | 0.39% | +4.3% |
| Q4 2019 | $1,711,000 | -50.9% | 105,429 | -6.8% | 0.38% | -35.2% |
| Q1 2018 | $3,483,000 | -9.2% | 113,096 | +5.4% | 0.58% | -15.6% |
| Q4 2017 | $3,837,000 | +92.0% | 107,333 | +48.0% | 0.69% | +158.3% |
| Q3 2017 | $1,998,000 | +123.2% | 72,518 | +113.9% | 0.27% | +79.7% |
| Q2 2017 | $895,000 | -74.5% | 33,897 | -67.0% | 0.15% | -67.8% |
| Q4 2015 | $3,512,000 | +96.1% | 102,800 | +95.2% | 0.46% | +35.0% |
| Q2 2014 | $1,791,000 | – | 52,668 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |